Global Collagen and HA-Based Biomaterials Market to Reach US$3.7 Billion by 2017, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Collagen and HA-based Biomaterials market. The global market for Collagen and HA-based Biomaterials is forecast to reach US$3.7 billion by the year 2017, primarily driven by heightened interest in personal healthcare, and growing size of aging population. Factors such as technological and process breakthroughs, and new vistas in implantable devices, tissue engineering, bone grafting substance, and facial aesthetic dermal implants would contribute to higher growth rates in terms of preference/choice of treatment in future.

Collagen and HA-Based Biomaterials: A Global Strategic Business Report

Follow us on LinkedIn – Biomaterials are of vital importance in the medical device industry, both for the discovery and development of synthetic organs, aesthetic procedures, and personal healthcare products. Biomaterials are mainly used in engineering new products to enhance personal appearance, which challenges the aging process. Primary consumers for anti-aging products include baby boomers and working women. Baby boomers constitute the single largest age group, driving the collagen and hyaluronic acid products market. This age group is the most rapidly expanding sector and the most desirous to access anti-aging treatment. The Middle aged baby boomers are more concerned about health and their physical appearance. Consumers over the age of 35-50 years are prominent users of facial aesthetic dermal implants.

As stated by the new market research report on Collagen and HA-based Biomaterials, the US continues to remain the largest regional market. The US market is primarily driven by rapid increase in aging population, and personal healthcare awareness. Rest of the World represents the fastest growing regional market, displaying a CAGR of 11.5% over the analysis period. Hyaluronic Acid-based (HA-based) Biomaterials constitute the largest segment compared to the Collagen-based biomaterials. Among the Hyaluronic Acid-based Biomaterials, Viscosupplements constitutes the largest segment, while Facial Aesthetic Dermal Implants segment is poised to register the fastest growth over the analysis period.

Growth in aging population worldwide continues to propel the demand for biomaterials in the treatment of osteoarthritis, cataracts, and wrinkles. A promising market for collagen and HA based biomaterials arises from the expanding size of aging population in developed countries. R&D investments in the industry are currently focused on the supply of new safer biomaterials. Development of novel biomaterials depends on the new R&D proceedings, testing methods, and manufacturing processes. Overall, the market for biomaterials is influenced by factors, such as industry dynamics, population demographics, product compatibility, supply chain, healthcare financing, product-liability legislation, and regulatory standards.

Device manufacturers face shortage of biomaterials due to the restricted supply. This uncertainty also affects the “off-the-shelf” usage of biomaterials in other industries. Biomaterial shortage largely affects medical device manufacturers to store or to choose alternative materials. Conditions could affect products, surgical procedures, which use biomaterials. This includes implantable medical devices such as heart valves, hydrocephalus shunts, orthopedic prostheses, and intraocular lenses.

Biomaterials market landscape is likely to change with the introduction of new products. Consumers always expect products that are effective for long time and have fewer side effects. Collagen based biomaterials are well established in the market, but due to side effects, new innovative products have started capturing its market share. For instance, botulinum toxin product Botox is forecast to penetrate further with more end use applications. Botox is now much more widely used than collagen worldwide. Collagen also faces stiff competition from the newly introduced Hyaluronic Acid based facial injections.

Major players profiled in the report include Genzyme Inc., Alcon Inc., Anika Therapeutics, Inc., Bausch & Lomb, Advanced Medical Optics, Sanofi-Aventis, Lincoln Pharmaceuticals, Medtronic Inc., Merz Pharma Group, Teijin Pharma Ltd., among others.

The research report titled "Collagen and HA-Based Biomaterials: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of the current market scenario, market dynamics, trends and issues, product overview, segment overview, technological research & developments, recent product introductions/innovations, strategic corporate initiatives, and profiles of major/niche global and regional companies worldwide. The report provides annual market size estimates and projections (in US$ Million) for the years 2009 through 2017 for the geographic markets US, Canada, Japan, Europe (France, Germany, Italy, UK and Rest of Europe), and Rest of World. Key product segments analyzed include Collagen- based Biomaterials (Urinary Incontinence Products, Corneal Shields, Facial Aesthetic Dermal Implants, and Wound Dressings); and Hyaluronic Acid-based Biomaterials (Viscosupplements, Viscoelastics, and Facial Aesthetic Dermal Implants). Also, a six-year (2003-2008) historic analysis is provided for additional perspective.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports, and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website